Edition:
United States

Zhejiang CONBA Pharmaceutical Co Ltd (600572.SS)

600572.SS on Shanghai Stock Exchange

6.67CNY
22 Jul 2016
Change (% chg)

¥-0.06 (-0.89%)
Prev Close
¥6.73
Open
¥6.73
Day's High
¥6.78
Day's Low
¥6.64
Volume
17,194,883
Avg. Vol
15,259,787
52-wk High
¥12.12
52-wk Low
¥6.00

Latest Key Developments (Source: Significant Developments)

Zhejiang Conba Pharmaceutical to pay 2015 dividend on June 15
Tuesday, 7 Jun 2016 02:24am EDT 

Zhejiang Conba Pharmaceutical Co., Ltd. <600572.SS> : Says it will pay a cash dividend of 1 yuan (before tax) per 10 shares and use additional paid-in capital to distribute five new shares for every 10 shares for 2015, to shareholders of record on June 14 .Says the company's shares will be traded ex-right and ex-dividend on June 15 and the dividend will be paid on June 15.  Full Article

Zhejiang CONBA Pharmaceutical unit gets nod for clinic trial
Wednesday, 27 Apr 2016 08:00pm EDT 

Zhejiang CONBA Pharmaceutical Co Ltd:Says its unit gets China Food and Drug Administration's approval for its symbya's clinic trial.  Full Article

Zhejiang CONBA Pharmaceutical unit gets nod for clinic trial
Monday, 18 Apr 2016 08:00pm EDT 

Zhejiang CONBA Pharmaceutical Co Ltd:Says its unit gets China Food and Drug Administration's approval for its ibuprofen injection's clinic trial.  Full Article

Zhejiang CONBA Pharmaceutical announces 2015 dividend payment
Monday, 11 Apr 2016 08:00pm EDT 

Zhejiang CONBA Pharmaceutical Co Ltd:Says it will pay a cash dividend of 1.0 yuan (pre-tax) for every 10 shares, and use additional paid-in capital to distribute 5 new shares for every 10 shares, to shareholders for 2015.  Full Article

Zhejiang CONBA Pharmaceutical unit gets nod for clinic trial
Monday, 7 Mar 2016 07:00pm EST 

Zhejiang CONBA Pharmaceutical Co Ltd:Says its unit gets China Food and Drug Administration's approval for its sodium picosulfate's clinic trial.  Full Article

Zhejiang CONBA Pharmaceutical to issue 1.1 bln yuan worth of corporate bonds
Tuesday, 1 Mar 2016 07:00pm EST 

Zhejiang CONBA Pharmaceutical Co Ltd:To issue 1.1 bln yuan worth of corporate bonds with a par value of 100 yuan per share.The bonds with a term of five years.The proceeds will be used for debt repayment and supplement of working capital.  Full Article

Zhejiang CONBA Pharmaceutical sub-subsidiary receives human clinical trials license from HSA and CIRB
Monday, 29 Feb 2016 07:00pm EST 

Zhejiang CONBA Pharmaceutical Co Ltd:Says Hong Kong-based wholly owned subsidiary's 18 pct owned subsidiary receives human clinical trials license from Singapore Health Sciences Authority(HSA) and SingHealth Centralised Institutional Review Board (CIRB), for recombinant super compound interferon (big dose of 27μ g and 30μ g).  Full Article

Zhejiang CONBA Pharmaceutical unit gets nod for clinic trial
Tuesday, 23 Feb 2016 07:00pm EST 

Zhejiang CONBA Pharmaceutical Co Ltd:Says its unit gets China Food and Drug Administration's approval for its acetylcysteine capsules and granules' clinic trial.  Full Article

Zhejiang CONBA Pharmaceutical gets nod for clinic trial
Thursday, 28 Jan 2016 07:00pm EST 

Zhejiang CONBA Pharmaceutical Co Ltd:Says gets China Food and Drug Administration's approval for its olanzapine tablets' clinic trial.  Full Article

Zhejiang CONBA Pharmaceutical subsidiary to withdraw the drug registration application
Thursday, 21 Jan 2016 07:00pm EST 

Zhejiang CONBA Pharmaceutical Co Ltd:Zhejiang-based subsidiary to withdraw the N-acetylcysteine acidic solution drug registration application.  Full Article